By KAI ICHINO/ Staff Writer
December 23, 2021 at 18:59 JST
Aducanumab, a drug for Alzheimer’s disease jointly developed by Eisai Co. and Biogen Inc. (Provided by Biogen Inc.)
A health ministry expert panel deferred approving the use of aducanumab as a treatment for Alzheimer's-type dementia, citing a need for more data on the drug’s efficacy through a clinical trial that will take years. [Read More]
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
